Current affiliation: Universitat de BarcelonaSubject: StatisticsPrimary location: Spain
Published in:Pharmaceutical StatisticsPublication date:2015-07-14
Carryover negligibility and relevance in bioequivalence studies
Published in:Statistics in MedicinePublication date:2015-12-28
Consumer's risk in the EMA and FDA regulatory approaches for bioequivalence in highly variable drugs
Published in:Statistics in MedicinePublication date:2017-08-29
The development cost of a new drug is very high. Any drug goes through different development phases where thousands of patients are included in cli...